ACAD financing

ACAD had a nice move today (up 13%) on news that it was raising $86M through a private sale of stock. It will be interesting to see if it can climb back to the mid-$6’s where it opened on news of its Ph 3 success. I imagine that the next likely catalyst here is the announcement of a  partnership for further development of pimavanserin.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s